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ScienceDirect
journal homepage: http: / /www.kjms-onl ine.comLETTER TO THE EDITORUndifferentiated pancreatic carcinoma with
osteoclast-like giant cells: A rare entity with
potential misdiagnosis of a gastrointestinal
stromal tumor on preoperative evaluationTo the Editor,
Pancreatic giant cells with tumors are a rare neoplasm that
account for less than 1% of all reported pancreatic carci-
noma [1,2]. Rosai initially reported these tumors in 1968
[3]. Since 2010, the World Health Organization has renamed
these tumors undifferentiated pancreatic carcinoma with
osteoclast-like giant cells (UPC-OGC) [2].
A 75-year-old woman sustained general malaise and
tarry stool for a 2-month period. After a series survey, the
abdominal computed tomography (CT) revealed a mass
lesion at the paraduodenal space with mass effect to
adjacent organs without infiltration or invasion. The largest
diameter was 6.1 cm. The tumor comprised heterogeneous
cystic lesions, and the septum was enhanced. Our first
impression was a gastrointestinal stromal tumor (GIST) from
the duodenum (Figure 1A). The patient underwent subse-
quent surgical tumor resection. During the operation, we
encountered one pancreatic head tumor with duodenal
invasion rather than a GIST. Finally, we performed pan-
creaticoduodenectomy and lymph node dissection for a
complete free tumor margin.
The pathology indicated numerous polygonal discohesive
cells or spindle cells. Highly anaplastic tumor cells con-
taining bizarre tumor giant cells and numerous OGCs were
also documented (Figure 1B). Immunohistochemistry with
pan-cytokeratin (AE1/AE3) demonstrated epithelial differ-
entiation of tumor cells (Figure 1C). The osteoclast-like
cells were positive for CD68, but negative for pan-
cytokeratin expression (Figure 1D). The final diagnosis was
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be differentiated from the most common ductal adeno-
carcinoma. On ultrasonography, the tumor is usually hypo-
echoic and heterogeneous [1].
The CT image tends to demonstrate a well-demarcated,
heterogeneous cystic tumor [4]. Common CT appearance of
GIST is bright and well enhanced, larger GIST may appear
with a heterogeneous center due to internal necrosis,
hemorrhage, or degeneration. When tumors appear on the
pancreatic head, these similar image appearances may
make preoperative evaluation problematic and difficult.
Therefore, surgical resection with subsequent pathological
examinations is the most suitable way for diagnosis and
treatment. Even with surgical resection, the risk of misdi-
agnosis still exists. Daum et al. [5] described one UPC-OGC
with irregular distribution of neoplastic cells and OGCs. The
malignant cells were documented in only five of the
investigated slides, and this resulted in a risk of misdiag-
nosis between UPC-OGC and GIST [5].
In pathologic examinations, UPC-OGC was positive for
CD68, vimentin, and lack of cytokeratin expression [2].
Conversely, GISTs were mostly positive for CD117. More
than 90% of GISTs are KIT positive, and platelet-derived
growth factor receptor alpha is expression positive in the
other KIT-negative GISTs [5]. These features can provide
some clues to differentiate UPC-OGC from GIST [5].
UPC-OGC is a rare malignant neoplasm. When the tumor
lesion appears on the pancreatic head, the image features
may cause misdiagnosis as a GIST from the duodenum. We
must be careful regarding the differential diagnosis be-
tween UPC-OGC and GIST, because misdiagnosis will result
in a completely different treatment program and affect
patient prognosis. Surgical resection is the suitable and
dependable method for diagnosis and treatment. They Elsevier Taiwan LLC. This is an open access article under the CC
).
Figure 1. (A) Heterogeneous mass lesion at the paraduodenal space. The largest diameter is 6.1 cm. The invasion of duodenal
mucosa is suspicious for GIST from the duodenum. There is mass effect to adjacent organs including the pancreas, but no vessel
invasions or regional lymph node metastasis; (B) there are highly anaplastic tumor cells containing bizarre tumor giant cells. Some
OGCs (arrow) are present; (C) immunohistochemical staining of pan-cytokeratin (AE1/AE3) demonstrate epithelial differentiation
of tumor cells; (D) the osteoclast-like cells are positive for CD68 but negative for pan-cytokeratin expression.
GIST Z gastrointestinal stromal tumor; OGC Z osteoclast-like giant cells.
594 Letter to the Editorhistological features and immunohistochemical staining are
very important and assist in a correct diagnosis.
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